Latest Breaking News On - Mark litton - Page 3 : comparemela.com

Athira Pharma (ATHA) Reports Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton

Athira Pharma (ATHA) Reports Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark littonHans moebiusAthira pharma incKevin churchAthira pharmaChief medical officerChief scientific officerChief executive officer

Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson s Disease Dementia and Dementia with Lewy Bodies

Exploratory findings add to increasing body of clinical and preclinical data supporting positive modulation of the neurotrophic HGF system as a potential therapeutic approach for neurodegenerative.

United statesAthira pharmaMark littonJulie rathbunHans moebiusExchange commissionAthira pharma incKevin churchSecurities exchangeChief medical officerChief scientific officerChief executive officerGlobal statistical testSecurities actSecurities exchange actPrivate securities litigation reform act

Athira Pharma Announces Upcoming Presentation At Motor Neurone Disease Association S 34ᵗʰ International Symposium On ALS/MND

Athira Pharma Announces Upcoming Presentation At Motor Neurone Disease Association S 34ᵗʰ International Symposium On ALS/MND
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesJulie rathbunMark littonAthira pharmaInternational symposiumAthira pharma incExchange commissionMotor neurone disease associationSecurities exchangeKevin churchPreclinical therapeuticChief scientific officerChief executive officerScientific publicationsSecurities actSecurities exchange act

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association s 34ᵗʰ International Symposium on ALS/MND

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association s 34ᵗʰ International Symposium on ALS/MND
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMark littonJulie rathbunAthira pharmaSecurities exchangeInternational symposiumExchange commissionMotor neurone disease associationKevin churchAthira pharma incPreclinical therapeuticChief scientific officerChief executive officerScientific publicationsSecurities actSecurities exchange act

Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates

Continues to report clinical and preclinical findings supporting the potential benefits of its small molecule therapeutic candidates targeting the.

United statesJulie rathbunSharay settiMark littonAthira pharmaWei wuWaltere washington convention centerDrug administrationDevelopment of novel therapies for neurodegenerativeSociety for neuroscienceClinical development pipeline programsSecurities exchangeAlzheimer association international conferenceAthira pharma incDevelopment rd expensesExchange commission